Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
4’692 JPY | +0.62% | +5.60% | +21.18% |
19.04. | Spannungen im Nahen Osten dämpfen asiatische Aktienmärkte | MT |
10.04. | Diagnostischer Test für metastasierenden Brustkrebs mit niedrigem HER2-Gehalt von Roche erhält CE-Kennzeichnung | MT |
ETFs investiert in Daiichi Sankyo Co., Ltd.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
25,16% | 15 M€ | +6.12% | ||
4,18% | 251 M€ | +12.23% | ||
3,32% | 174 M€ | -.--% | - | |
3,32% | 51 M€ | -.--% | - | |
3,24% | 15 M€ | +14.64% | ||
2,78% | 81 M€ | +14.29% | ||
2,69% | 57 M€ | +19.82% | ||
2,19% | 14 M€ | +17.50% | ||
2,13% | 73 M€ | +11.61% | ||
1,96% | 10 207 M€ | +15.12% | ||
1,95% | 5 115 M€ | +15.03% | ||
1,71% | 26 M€ | +20.74% | ||
1,68% | 16 729 M€ | +14.82% | - | |
1,64% | 31 732 M€ | +15.79% | - | |
1,63% | 1 198 M€ | +15.05% | - | |
1,42% | 66 066 M€ | +15.74% | - | |
1,42% | 144 586 M€ | +15.64% | ||
1,42% | 20 721 M€ | +14.53% | - | |
1,35% | 18 M€ | +16.15% | - | |
1,29% | 4 M€ | +13.95% | ||
1,08% | 60 M€ | +15.41% | ||
0,99% | 67 864 M€ | +15.67% | ||
0,69% | 4 M€ | -.--% | - | |
0,68% | 717 M€ | +5.89% | ||
0,44% | 26 M€ | +1.63% | - | |
0,30% | 10 M€ | -3.35% | - | |
0,30% | 36 M€ | +1.76% | - | |
0,25% | 7 M€ | +1.91% | - | |
0,23% | 276 M€ | +11.40% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+21.18% | 57.77 Mrd. | |
+27.92% | 672 Mrd. | |
+27.68% | 570 Mrd. | |
-4.59% | 360 Mrd. | |
+16.38% | 321 Mrd. | |
+9.39% | 300 Mrd. | |
+6.30% | 217 Mrd. | |
+4.80% | 199 Mrd. | |
-6.05% | 204 Mrd. | |
-8.58% | 149 Mrd. |
- Börse
- Aktien
- A0F57T Aktie
- ETFs Daiichi Sankyo Co., Ltd.